In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugois a multifunctional targeted therapy drug, which can be used as a small···【more】
Release date:2024-08-23Recommended:521
Koselugo is a targeted therapy that targets specific cancers by inhibiting the a···【more】
Release date:2024-08-23Recommended:536
Koselugo is a targeted therapy drug for the treatment of low-grade serous ovaria···【more】
Release date:2024-08-23Recommended:533
Koselugois an anti-cancer drug targeting MEK protein, which can successfully blo···【more】
Release date:2024-08-23Recommended:514
Koselugo is an MEK protein-targeted anticancer agent that can effectively cut th···【more】
Release date:2024-08-23Recommended:522
Koselugo is an anti-cancer drug targeting MEK protein, which inhibits tumor cell···【more】
Release date:2024-08-23Recommended:588
By targeting and inhibiting the activity of MEK protein, Koselugo effectively cu···【more】
Release date:2024-08-23Recommended:508
Koselugoinhibits tumor cell proliferation by inhibiting MEK protein activity, bl···【more】
Release date:2024-08-23Recommended:464
Koselugo is a targeted therapy drug primarily used to treat a specific subtype o···【more】
Release date:2024-08-23Recommended:507
Alpelisib is a drug for the treatment of HR/HER2- breast cancer, especially for ···【more】
Release date:2024-08-22Recommended:527
Alpelisib for the treatment of PIK3CA-mutated HR/HER2- advanced breast cancer in···【more】
Release date:2024-08-22Recommended:545
Alpelisib, approved in combination with fulvestrant in 2019 for the treatment of···【more】
Release date:2024-08-22Recommended:554